Liu LS - Search Results

1

Telmisartan, ramipril, or both in high-risk Chinese patients: analysis of ONTARGET China data.

Yu LT, Zhu J, Tan HQ, Wang GG, Teo KK, Liu LS. Yu LT, et al. Among authors: liu ls. Chin Med J (Engl). 2011 Jun;124(12):1763-8. Chin Med J (Engl). 2011. PMID: 21740829 Clinical Trial.

2

Community control of hypertension.

Liu L. Liu L. Chin Med J (Engl). 1996 Feb;109(2):99-102. Chin Med J (Engl). 1996. PMID: 8758323 Review. No abstract available.

3

Hypertension with identifiable cause. Secondary hypertension.

Liu L. Liu L. Chin Med J (Engl). 1996 Dec;109(12):909-18. Chin Med J (Engl). 1996. PMID: 9275320 Review. No abstract available.

4

Long-term mortality in patients with myocardial infarction: impact of early treatment with captopril for 4 weeks.

Liu L; Chinese Cardiac Study (CCS-I) Collaborative Group. Liu L, et al. Chin Med J (Engl). 2001 Feb;114(2):115-8. Chin Med J (Engl). 2001. PMID: 11780187 Clinical Trial.

5

Challenges in the conduct of large simple trials of important generic questions in resource-poor settings: the CREATE and ECLA trial program evaluating GIK (glucose, insulin and potassium) and low-molecular-weight heparin in acute myocardial infarction.

Yusuf S, Mehta SR, Díaz R, Paolasso E, Pais P, Xavier D, Xie C, Ahmed RJ, Khazmi K, Zhu J, Liu L; CREATE-ECLA investigators and steering committee. Yusuf S, et al. Am Heart J. 2004 Dec;148(6):1068-78. doi: 10.1016/j.ahj.2004.08.033. Am Heart J. 2004. PMID: 15632895 Free PMC article.

6

Effects of reviparin, a low-molecular-weight heparin, on mortality, reinfarction, and strokes in patients with acute myocardial infarction presenting with ST-segment elevation.

Yusuf S, Mehta SR, Xie C, Ahmed RJ, Xavier D, Pais P, Zhu J, Liu L; CREATE Trial Group Investigators. Yusuf S, et al. JAMA. 2005 Jan 26;293(4):427-35. doi: 10.1001/jama.293.4.427. JAMA. 2005. PMID: 15671427 Clinical Trial.

7

Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial.

Mehta SR, Yusuf S, Díaz R, Zhu J, Pais P, Xavier D, Paolasso E, Ahmed R, Xie C, Kazmi K, Tai J, Orlandini A, Pogue J, Liu L; CREATE-ECLA Trial Group Investigators. Mehta SR, et al. JAMA. 2005 Jan 26;293(4):437-46. doi: 10.1001/jama.293.4.437. JAMA. 2005. PMID: 15671428 Clinical Trial.

8

[Risk factors of sudden death and death from arrhythmia in patients with non-ST elevation acute coronary syndromes in China].

Liang Y, Tan HQ, Zhu J, Zhang Y, Liu LS; Chinese Coordinating Center for Organization to Assess Strategies for Ischemic Syndromes. Liang Y, et al. Among authors: liu ls. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2005 Mar;17(3):142-5. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2005. PMID: 15760521 Chinese.

9

[Two year follow-up of acute ischemic syndrome without ST elevation].

Tan HQ, Zhu J, Liang Y, Zhang Y, Liu LS; Chinese Coordinating Center of OASIS Registry. Tan HQ, et al. Among authors: liu ls. Zhonghua Yi Xue Za Zhi. 2005 Jan 19;85(3):184-8. Zhonghua Yi Xue Za Zhi. 2005. PMID: 15854465 Chinese.

10

[The influencing factors of surviving time of patients with non-ST elevation acute coronary syndromes in China].

Liang Y, Zhu J, Tan HQ, Li JD, Liu LS. Liang Y, et al. Among authors: liu ls. Zhonghua Yi Xue Za Zhi. 2005 Apr 6;85(13):873-8. Zhonghua Yi Xue Za Zhi. 2005. PMID: 16029522 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

468 results

Search Page

Filters